Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
B-Lymphocytes | 20 | 2024 | 4793 | 2.290 |
Why?
|
Immunoglobulin E | 7 | 2024 | 1506 | 2.000 |
Why?
|
Immunoglobulin Class Switching | 10 | 2017 | 289 | 1.860 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2018 | 547 | 1.520 |
Why?
|
Immunoglobulins | 5 | 2019 | 855 | 1.510 |
Why?
|
Immunoglobulin Heavy Chains | 8 | 2023 | 648 | 1.310 |
Why?
|
Immunoglobulin G | 7 | 2024 | 4568 | 0.950 |
Why?
|
Antibody Affinity | 3 | 2021 | 252 | 0.750 |
Why?
|
Antibody Formation | 3 | 2023 | 1393 | 0.700 |
Why?
|
Common Variable Immunodeficiency | 2 | 2019 | 100 | 0.690 |
Why?
|
Symbiosis | 3 | 2018 | 297 | 0.690 |
Why?
|
Measles virus | 1 | 2019 | 67 | 0.670 |
Why?
|
Antibodies, Viral | 8 | 2022 | 3214 | 0.600 |
Why?
|
Mycoplasma Infections | 1 | 2018 | 120 | 0.590 |
Why?
|
Measles | 1 | 2019 | 180 | 0.570 |
Why?
|
Autoimmunity | 2 | 2023 | 1361 | 0.570 |
Why?
|
Peanut Hypersensitivity | 1 | 2020 | 219 | 0.550 |
Why?
|
Biological Therapy | 1 | 2018 | 140 | 0.540 |
Why?
|
Immunoglobulin M | 2 | 2021 | 1528 | 0.540 |
Why?
|
Lymphocyte Activation | 5 | 2024 | 5505 | 0.500 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 282 | 0.500 |
Why?
|
Germinal Center | 1 | 2017 | 380 | 0.480 |
Why?
|
Autoantibodies | 1 | 2023 | 2121 | 0.450 |
Why?
|
Intestinal Mucosa | 2 | 2016 | 3044 | 0.440 |
Why?
|
Tight Junctions | 1 | 2016 | 324 | 0.430 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 667 | 0.430 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2024 | 4415 | 0.430 |
Why?
|
Vaccines | 1 | 2022 | 843 | 0.420 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1381 | 0.420 |
Why?
|
Immunoglobulin epsilon-Chains | 1 | 2011 | 16 | 0.400 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 4 | 2015 | 111 | 0.400 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2011 | 62 | 0.390 |
Why?
|
Immunity, Humoral | 2 | 2020 | 610 | 0.390 |
Why?
|
Cell Lineage | 3 | 2019 | 2575 | 0.380 |
Why?
|
Recombination, Genetic | 3 | 2011 | 1525 | 0.350 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 940 | 0.340 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1546 | 0.310 |
Why?
|
Food Hypersensitivity | 1 | 2016 | 734 | 0.300 |
Why?
|
Epitopes | 5 | 2022 | 2527 | 0.300 |
Why?
|
Immune Evasion | 2 | 2021 | 375 | 0.290 |
Why?
|
Animals | 33 | 2024 | 169285 | 0.280 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3781 | 0.280 |
Why?
|
Antiphospholipid Syndrome | 1 | 2009 | 167 | 0.280 |
Why?
|
Bacteria | 1 | 2018 | 2216 | 0.280 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4786 | 0.270 |
Why?
|
Interferon-gamma | 3 | 2004 | 3161 | 0.270 |
Why?
|
Germ-Free Life | 2 | 2018 | 187 | 0.250 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3670 | 0.250 |
Why?
|
Immunoglobulin A | 2 | 2021 | 992 | 0.250 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 809 | 0.250 |
Why?
|
Macrophages | 4 | 2004 | 5802 | 0.250 |
Why?
|
Clone Cells | 2 | 2019 | 1670 | 0.240 |
Why?
|
Carrier Proteins | 4 | 2023 | 4939 | 0.230 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2004 | 44 | 0.230 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2003 | 588 | 0.230 |
Why?
|
DNA Breaks, Double-Stranded | 5 | 2013 | 606 | 0.220 |
Why?
|
Epitope Mapping | 2 | 2023 | 301 | 0.210 |
Why?
|
Sarcoidosis | 1 | 2009 | 535 | 0.210 |
Why?
|
Immune System | 2 | 2019 | 800 | 0.210 |
Why?
|
Dermatitis, Atopic | 2 | 2024 | 737 | 0.210 |
Why?
|
Mice | 22 | 2024 | 82049 | 0.210 |
Why?
|
DNA-Binding Proteins | 9 | 2013 | 9617 | 0.200 |
Why?
|
Immunodominant Epitopes | 1 | 2023 | 244 | 0.200 |
Why?
|
Hypersensitivity | 2 | 2024 | 1172 | 0.200 |
Why?
|
Immunoglobulin Light Chains | 1 | 2023 | 289 | 0.200 |
Why?
|
DNA Repair | 4 | 2012 | 2050 | 0.190 |
Why?
|
Humans | 42 | 2024 | 768171 | 0.180 |
Why?
|
Host-Pathogen Interactions | 2 | 2023 | 1469 | 0.180 |
Why?
|
Plasma Cells | 1 | 2024 | 599 | 0.180 |
Why?
|
Antigens | 2 | 2017 | 1443 | 0.180 |
Why?
|
Amino Acid Motifs | 1 | 2023 | 930 | 0.180 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1887 | 0.180 |
Why?
|
Interleukin-4 | 1 | 2024 | 1156 | 0.170 |
Why?
|
Membrane Fusion | 1 | 2021 | 265 | 0.170 |
Why?
|
Immunologic Memory | 2 | 2024 | 1377 | 0.170 |
Why?
|
Interferon-Stimulated Gene Factor 3 | 3 | 2004 | 10 | 0.170 |
Why?
|
Antigens, Plant | 1 | 2020 | 104 | 0.170 |
Why?
|
Immunity, Cellular | 2 | 2023 | 1561 | 0.170 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7477 | 0.160 |
Why?
|
Antibody Diversity | 1 | 2019 | 72 | 0.160 |
Why?
|
Mutation | 5 | 2022 | 30237 | 0.160 |
Why?
|
Plateletpheresis | 1 | 2018 | 38 | 0.160 |
Why?
|
Antibodies, Neutralizing | 4 | 2022 | 2009 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1078 | 0.160 |
Why?
|
Vaccines, DNA | 1 | 2020 | 279 | 0.160 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 287 | 0.160 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 103 | 0.150 |
Why?
|
Mycoplasma hominis | 1 | 2018 | 10 | 0.150 |
Why?
|
Cysteine | 1 | 2023 | 897 | 0.150 |
Why?
|
Haptens | 1 | 2017 | 163 | 0.150 |
Why?
|
Sampling Studies | 1 | 2019 | 615 | 0.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2013 | 724 | 0.140 |
Why?
|
Skin | 2 | 2024 | 4505 | 0.140 |
Why?
|
Granuloma | 1 | 2019 | 329 | 0.140 |
Why?
|
Immunoglobulin Variable Region | 1 | 2018 | 420 | 0.140 |
Why?
|
Molecular Conformation | 1 | 2017 | 540 | 0.130 |
Why?
|
Blood Donors | 1 | 2018 | 343 | 0.130 |
Why?
|
Central Nervous System | 1 | 2004 | 1346 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2171 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1361 | 0.130 |
Why?
|
Lymphopenia | 1 | 2018 | 300 | 0.130 |
Why?
|
Antigens, CD | 2 | 2003 | 4035 | 0.130 |
Why?
|
Precursor Cells, B-Lymphoid | 2 | 2013 | 99 | 0.130 |
Why?
|
Transcription Factors | 3 | 2004 | 12171 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3814 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2003 | 4355 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2003 | 2982 | 0.120 |
Why?
|
Models, Molecular | 3 | 2021 | 5402 | 0.120 |
Why?
|
Peyer's Patches | 1 | 2015 | 120 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 596 | 0.120 |
Why?
|
Microglia | 1 | 2004 | 1376 | 0.120 |
Why?
|
Gene Conversion | 1 | 2014 | 69 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 175 | 0.120 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.120 |
Why?
|
Autoantigens | 1 | 2019 | 890 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 2018 | 498 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2018 | 549 | 0.110 |
Why?
|
Trypsin | 1 | 2014 | 491 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1623 | 0.110 |
Why?
|
Translocation, Genetic | 2 | 2010 | 1394 | 0.110 |
Why?
|
Spleen | 2 | 2018 | 2296 | 0.110 |
Why?
|
Weaning | 1 | 2013 | 102 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 219 | 0.110 |
Why?
|
DNA Ligases | 2 | 2010 | 81 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1662 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2747 | 0.100 |
Why?
|
Cervix Uteri | 1 | 2017 | 577 | 0.100 |
Why?
|
Cell Differentiation | 2 | 2024 | 11677 | 0.100 |
Why?
|
Virus Replication | 1 | 2021 | 2458 | 0.100 |
Why?
|
Chickens | 1 | 2014 | 845 | 0.100 |
Why?
|
Antigens, Nuclear | 2 | 2010 | 183 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.100 |
Why?
|
Telomere-Binding Proteins | 1 | 2013 | 122 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3238 | 0.100 |
Why?
|
Cattle | 1 | 2018 | 3819 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2003 | 257 | 0.100 |
Why?
|
Sheep | 1 | 2014 | 1451 | 0.100 |
Why?
|
Pneumonectomy | 1 | 2019 | 1156 | 0.100 |
Why?
|
Cytidine Deaminase | 2 | 2011 | 249 | 0.100 |
Why?
|
Intestine, Small | 1 | 2018 | 1217 | 0.100 |
Why?
|
Vagina | 1 | 2017 | 850 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2023 | 12801 | 0.090 |
Why?
|
Cytokines | 2 | 2004 | 7452 | 0.090 |
Why?
|
Exoribonucleases | 1 | 2011 | 88 | 0.090 |
Why?
|
Cytological Techniques | 1 | 2012 | 218 | 0.090 |
Why?
|
Desensitization, Immunologic | 1 | 2016 | 558 | 0.090 |
Why?
|
Cell Line | 5 | 2021 | 15602 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 553 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10266 | 0.090 |
Why?
|
Immunoglobulin Switch Region | 1 | 2010 | 44 | 0.090 |
Why?
|
Genetic Techniques | 1 | 2012 | 428 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2002 | 4206 | 0.080 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2009 | 62 | 0.080 |
Why?
|
Protein Conformation | 3 | 2021 | 3956 | 0.080 |
Why?
|
Multigene Family | 1 | 2012 | 1081 | 0.080 |
Why?
|
Biosensing Techniques | 1 | 2015 | 662 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2568 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15949 | 0.080 |
Why?
|
Cross Reactions | 2 | 2021 | 828 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2021 | 3080 | 0.080 |
Why?
|
Genes, Immunoglobulin | 1 | 2009 | 286 | 0.080 |
Why?
|
Rabbits | 1 | 2014 | 4773 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7609 | 0.070 |
Why?
|
Blood Platelets | 1 | 2018 | 2479 | 0.070 |
Why?
|
Homeostasis | 2 | 2017 | 3348 | 0.070 |
Why?
|
Multienzyme Complexes | 1 | 2011 | 664 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2021 | 995 | 0.070 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 923 | 0.070 |
Why?
|
Transfection | 3 | 2003 | 5756 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22380 | 0.070 |
Why?
|
Cell Separation | 1 | 2012 | 1728 | 0.070 |
Why?
|
Cryoelectron Microscopy | 2 | 2021 | 648 | 0.070 |
Why?
|
Signal Transduction | 3 | 2004 | 23648 | 0.070 |
Why?
|
Protein Binding | 3 | 2023 | 9343 | 0.070 |
Why?
|
Male | 10 | 2023 | 364731 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2017 | 5902 | 0.060 |
Why?
|
Child Development | 1 | 2017 | 2330 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2414 | 0.060 |
Why?
|
Down-Regulation | 2 | 2003 | 2939 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11095 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2024 | 14488 | 0.060 |
Why?
|
Swine | 1 | 2014 | 5997 | 0.060 |
Why?
|
NF-kappa B | 2 | 2003 | 2494 | 0.060 |
Why?
|
TNF Receptor-Associated Death Domain Protein | 1 | 2004 | 5 | 0.060 |
Why?
|
Life Style | 1 | 2016 | 3932 | 0.060 |
Why?
|
Molsidomine | 1 | 2003 | 22 | 0.060 |
Why?
|
Female | 11 | 2024 | 397187 | 0.060 |
Why?
|
Genome | 1 | 2012 | 1754 | 0.060 |
Why?
|
Peroxynitrous Acid | 1 | 2003 | 40 | 0.060 |
Why?
|
Reactive Nitrogen Species | 1 | 2003 | 35 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8747 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9262 | 0.050 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2022 | 27 | 0.050 |
Why?
|
Ovalbumin | 1 | 2024 | 677 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2004 | 432 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2004 | 528 | 0.050 |
Why?
|
DNA Damage | 1 | 2012 | 2469 | 0.050 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2002 | 178 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9540 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2002 | 146 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1435 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3396 | 0.050 |
Why?
|
RNA | 1 | 2011 | 2722 | 0.050 |
Why?
|
ABO Blood-Group System | 1 | 2023 | 381 | 0.050 |
Why?
|
Mesocricetus | 1 | 2021 | 256 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2004 | 557 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2810 | 0.040 |
Why?
|
Galectins | 1 | 2023 | 295 | 0.040 |
Why?
|
Interferon Type I | 1 | 2024 | 569 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2022 | 739 | 0.040 |
Why?
|
Histones | 1 | 2010 | 2601 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9561 | 0.040 |
Why?
|
Drug Synergism | 1 | 2003 | 1760 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3445 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 644 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2023 | 827 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1505 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 450 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5804 | 0.040 |
Why?
|
Genes, myc | 2 | 2010 | 391 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2020 | 488 | 0.040 |
Why?
|
RNA Precursors | 1 | 1999 | 196 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 760 | 0.040 |
Why?
|
Protein Subunits | 1 | 2021 | 943 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2020 | 373 | 0.040 |
Why?
|
Endoribonucleases | 1 | 1999 | 231 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39354 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 537 | 0.040 |
Why?
|
Cricetinae | 1 | 2021 | 2423 | 0.030 |
Why?
|
Protein Engineering | 1 | 2021 | 553 | 0.030 |
Why?
|
Prevotella | 1 | 2017 | 81 | 0.030 |
Why?
|
Nasal Mucosa | 1 | 2020 | 416 | 0.030 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 71 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2021 | 966 | 0.030 |
Why?
|
Middle Aged | 4 | 2023 | 223487 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2013 | 1676 | 0.030 |
Why?
|
Platelet Count | 1 | 2018 | 787 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 11930 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3284 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2003 | 2152 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20762 | 0.030 |
Why?
|
Lactobacillus | 1 | 2017 | 212 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2024 | 6231 | 0.030 |
Why?
|
RNA Interference | 1 | 2004 | 2832 | 0.030 |
Why?
|
Binding Sites | 1 | 2004 | 6019 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65379 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2003 | 1892 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 999 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 942 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 277 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2015 | 657 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10590 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2363 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2003 | 2956 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13677 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2023 | 19025 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4280 | 0.020 |
Why?
|
South Africa | 1 | 2017 | 1873 | 0.020 |
Why?
|
Alleles | 1 | 2022 | 6894 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2002 | 5797 | 0.020 |
Why?
|
Aged | 3 | 2018 | 171502 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4354 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2486 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2010 | 148 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17569 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 672 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20225 | 0.020 |
Why?
|
Adult | 3 | 2019 | 223646 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 866 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2010 | 775 | 0.020 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2009 | 83 | 0.020 |
Why?
|
Receptors, Complement 3d | 1 | 2009 | 117 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5315 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1121 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2721 | 0.020 |
Why?
|
Interphase | 1 | 2009 | 227 | 0.020 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2009 | 171 | 0.020 |
Why?
|
Genomic Instability | 1 | 2013 | 716 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2323 | 0.020 |
Why?
|
Glioblastoma | 1 | 2003 | 3464 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2234 | 0.020 |
Why?
|
Vaccination | 1 | 2020 | 3437 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6009 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3522 | 0.020 |
Why?
|
Integrases | 1 | 2009 | 520 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2013 | 1155 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14783 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2828 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14729 | 0.020 |
Why?
|
Base Sequence | 2 | 2010 | 12422 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 17142 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2521 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 17623 | 0.010 |
Why?
|
Health Care Costs | 1 | 2016 | 3239 | 0.010 |
Why?
|
Fibroblasts | 1 | 2013 | 4178 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2017 | 4543 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10840 | 0.010 |
Why?
|
Doxycycline | 1 | 2003 | 349 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18349 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2430 | 0.010 |
Why?
|
Chromatin | 1 | 2010 | 2981 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40220 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 30009 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 1750 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26421 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26379 | 0.010 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 1999 | 393 | 0.010 |
Why?
|
Nucleotides | 1 | 1999 | 455 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41753 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3590 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 60066 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74944 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 22371 | 0.000 |
Why?
|